Fanny Boursin
5PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Sep 05, 2025
Development of Optimized Exatecan-Based Immunoconjugates with Potent Antitumor Efficacy in HER2-Positive Breast Cancer.Etienne Auvert, Emmanuel Douez, Louis Jolivet
|Apr 18, 2025
Intranasal spike and nucleoprotein fusion protein-based vaccine provides cross-protection and reduced transmission against SARS-CoV-2 variants.Zineb Lakhrif, Agathe Poupée-Beaugé, Fanny Boursin
|Jan 08, 2025
Metformin-encapsulating immunoliposomes conjugated with anti-TROP 2 antibody fragments for the active targeting of triple-negative breast cancer.Daiva Vozgirdaite, Emilie Allard-Vannier, Florence Velge-Roussel
|Aug 23, 2022
Anticalin N- or C-Terminal on a Monoclonal Antibody Affects Both Production and In Vitro Functionality.Nicolas Aubrey, Valérie Gouilleux-Gruart, Christine Dhommée
|Jul 27, 2022
Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment-Drug Conjugates (FDCs).Louis Jolivet, Imène Ait Mohamed Amar, Catherine Horiot
Pageof 1
Frequent Collaborators
3 joint publications
Emilie Allard-Vannier
2 joint publications
Cyril Colas
2 joint publications
Caroline Denevault-Sabourin
2 joint publications
Nicolas Joubert
2 joint publications
Nicolas Aubrey
1 joint publications
Imène Ait Mohamed Amar
1 joint publications
Laurie Lajoie
1 joint publications
Florence Velge-Roussel
1 joint publications
Daiva Vozgirdaite
1 joint publications
Emmanuel Douez
